Warning: Risks With Improper Use Of Pyridostigmine Bromide
After Exposure to Soman, Use Atropine and Pralidoxime
- Pyridostigmine bromide is for use as a pretreatment for exposure to soman nerve agent. Pyridostigmine bromide alone will not protect against exposure to soman. The efficacy of pyridostigmine bromide is dependent upon the rapid use of atropine and pralidoxime (2-PAM) after soman exposure [see Dosage and Administration (2.1) and Warnings and Precautions (5.1)].
- Primary protection against exposure to chemical nerve agents is the wearing of protective garments including masks, hoods, and overgarments designed specifically for this use.
- Individuals must not rely solely upon pretreatment with pyridostigmine bromide and on the antidotes atropine and pralidoxime (2-PAM) to provide complete protection from poisoning by soman nerve agent [see Dosage and Administration (2.1)].
- If pyridostigmine bromide is taken immediately before exposure (e.g., when the gas attack alarm is given) or at the same time as poisoning by soman, it is not expected to be effective and may exacerbate the effects of a sublethal exposure to soman. Do not take pyridostigmine bromide after exposure to soman.[see Clinical Pharmacology (12.2)].
Always Use Protective Garment(s)
Pyridostigmine Bromide as Pretreatment Only
FOR MILITARY MEDICAL USE ONLY